Salvage Reconstructive Surgery During Nivolumab Therapy for a Patient With Hypopharyngeal Cancer

OBJECTIVES: Nivolumab, a fully IgG4-programmed death-1 inhibitor antibody, led to improved overall survival compared with single-agent therapy in patients with platinum-refractory recurrent head and neck cancers. In general, nivolumab is used in inoperable patients. To the best of our knowledge, the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Med Insights Case Rep
Autori principali: Tsushima, Nayuta, Shinozaki, Takeshi, Fujisawa, Takao, Tomioka, Toshifumi, Okano, Wataru, Ikeda, Masakazu, Tahara, Makoto, Higashino, Takuya, Hayashi, Ryuichi
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7169354/
https://ncbi.nlm.nih.gov/pubmed/32341668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179547620908854
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi